Respipure Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 3 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 72.18 Cr
About Respipure Pharma
Respipure Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 2022 (Three years 4 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹72.18 Cr.
Manish Mangilal, Nishant Vaish, and Shekhar Bhuwania serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290MH2022PTC375528
-
Company No.
375528
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jan 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Respipure Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shekhar Bhuwania
|
Director | 15-Jun-2022 | Current |
|
Manish Mangilal
|
Director | 27-Jan-2022 | Current |
|
Nishant Vaish
|
Director | 27-Jan-2022 | Current |
Financial Performance of Respipure Pharma.
Respipure Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Respipure Pharma?
In 2023, Respipure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Luna Apparels Private LimitedShekhar Bhuwania is a mutual person
-
Growthally Fintech Private LimitedShekhar Bhuwania is a mutual person
-
Growthally Advisors Private Limited
Shekhar Bhuwania is a mutual person
-
Growlease Private Limited
Shekhar Bhuwania is a mutual person
-
Oc Specialities Private LimitedManish Mangilal is a mutual person
-
Indira Consultancy LlpManish Mangilal is a mutual person
Charges (Loans)
₹72.18 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 72.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2023 | Hdfc Bank Limited | ₹33.54 Cr | Open |
| 19 Dec 2022 | Hdfc Bank Limited | ₹38.64 Cr | Open |
How Many Employees Work at Respipure Pharma?
Respipure Pharma has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Respipure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Respipure Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.